Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.04 - $1.86 $9,298 - $16,630
-8,941 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$1.44 - $5.62 $2,956 - $11,537
-2,053 Reduced 18.67%
8,941 $16,000
Q3 2021

Nov 15, 2021

SELL
$9.29 - $14.27 $159,565 - $245,101
-17,176 Reduced 60.97%
10,994 $103,000
Q2 2021

Aug 16, 2021

BUY
$13.3 - $17.3 $224,623 - $292,179
16,889 Added 149.71%
28,170 $389,000
Q1 2021

May 18, 2021

BUY
$11.89 - $35.55 $15,005 - $44,864
1,262 Added 12.6%
11,281 $157,000
Q4 2020

Feb 16, 2021

BUY
$15.0 - $35.15 $150,285 - $352,167
10,019 New
10,019 $324,000

About Oncorus, Inc.


  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.